Empire State Development and United Biochemicals announced June 27 that the company, a primary supplier of life sciences research products in Niagara County, will upgrade its manufacturing capabilities in response to evolving customer demands.
The nearly $1 million project, which includes machinery and equipment acquisition, renovations to the facility and soft costs, will create 22 new, full-time jobs and retain 31 employees.
The company offers several essential products to the life sciences industry throughout the nation and is a key supplier of these products to Western New York life science companies. Because of its location and manufacturing capabilities, United Biochemicals is able to provide unique products and services at an exceptionally low cost, benefiting life science companies in the Greater Buffalo-Niagara Region.
"Life sciences is a target industry for New York State and by providing critical assistance to growing small businesses in this sector, we can ensure that they have a bright future here in Western New York," said ESD President/CEO Kenneth Adams. "ESD's grant will not only help United Biochemicals remain in Sanborn, but will allow it to expand productivity and better compete in both new and existing markets."
ESD has provided a $150,000 capital grant that will be used to reimburse the company for a portion of the costs associated with its upgrade.
"Without the capital grant of $150,000 provided by ESD, United Biochemicals would not be able to complete its expansion project, which is essential for its growth, creating new jobs and playing a key role in the growth of Western New York life science companies," said United Biochemicals President Fayyaz Hussain.
Specific products manufactured by United Biochemicals are biological buffers, biochemicals, amino acid derivatives and custom sterile filtered solutions.